IMV Inc. (IMVIF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 | -38.67 Million USD | 3.88% |
| 2021 | -40.23 Million USD | -14.04% |
| 2020 | -35.27 Million CAD | -57.85% |
| 2019 | -22.35 Million CAD | -39.56% |
| 2018 | -16.01 Million USD | -62.64% |
| 2017 | -9.84 Million USD | -60.94% |
| 2016 | -6.11 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2022 Q4 | -8.93 Million USD | 5.85% |
| 2022 FY | -38.67 Million USD | 3.88% |
| 2022 Q1 | -10.75 Million USD | 7.16% |
| 2022 Q2 | -10.57 Million USD | 1.62% |
| 2022 Q3 | -9.49 Million USD | 10.27% |
| 2021 Q3 | -10.82 Million USD | 0.0% |
| 2021 FY | -40.23 Million USD | -14.04% |
| 2021 Q4 | -11.58 Million USD | -7.02% |
| 2020 FY | -35.27 Million CAD | -57.85% |
| 2019 FY | -22.35 Million CAD | -39.56% |
| 2018 FY | -16.01 Million USD | -62.64% |
| 2017 FY | -9.84 Million USD | -60.94% |
| 2016 FY | -6.11 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HST Global, Inc. | -140.9 Thousand USD | -27344.707% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -5529.451% |
| WPD Pharmaceuticals Inc. | -171.5 Thousand USD | -22447.733% |
| CytoDyn Inc. | -18.05 Million USD | -114.152% |
| RVL Pharmaceuticals plc | -58.99 Million USD | 34.444% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| MultiCell Technologies, Inc. | -722.81 USD | -5350062.975% |
| ImmunoCellular Therapeutics, Ltd. | -1.81 Million USD | -2029.113% |
| Arch Therapeutics, Inc. | -5.04 Million USD | -666.61% |
| THC Farmaceuticals, Inc. | -29.95 Thousand USD | -129011.622% |
| Reve Technologies, Inc. | -181.48 Thousand USD | -21208.38% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| Alpha Cognition Inc. | -9.7 Million USD | -298.445% |
| Northwest Biotherapeutics, Inc. | -55.5 Million USD | 30.332% |
| SQZ Biotechnologies Company | -75.82 Million USD | 48.999% |
| Resverlogix Corp. | -12.74 Million USD | -203.33% |
| Neon Bloom, Inc. | -389.57 Thousand USD | -9826.717% |
| VioQuest Pharmaceuticals, Inc. | 9.74 Million USD | 496.938% |
| Sigyn Therapeutics, Inc. | -2.45 Million USD | -1475.011% |
| Mesoblast Limited | -84.14 Million USD | 54.043% |
| GB Sciences, Inc. | -1.42 Million USD | -2622.37% |
| Regen BioPharma, Inc. | -686.95 Thousand USD | -5529.451% |
| Evofem Biosciences, Inc. | -17.84 Million USD | -116.684% |
| Inhibitor Therapeutics, Inc. | -3.4 Million USD | -1035.734% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -6.64 Million USD | -481.7% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Nuo Therapeutics, Inc. | -3.16 Million USD | -1120.586% |
| ContraFect Corporation | -56.88 Million USD | 32.023% |
| AXIM Biotechnologies, Inc. | -2.75 Million USD | -1305.808% |
| BioStem Technologies, Inc. | -7.77 Million USD | -397.129% |
| LadRx Corporation | -3.82 Million USD | -911.383% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -143.681% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -3355.899% |
| CSL Limited | 3.7 Billion USD | 101.045% |
| Biomind Labs Inc. | -1 Million USD | -3730.368% |
| CNBX Pharmaceuticals Inc. | -931.38 Thousand USD | -4052.066% |
| Santhera Pharmaceuticals Holding AG | 81.85 Million USD | 147.246% |
| Nascent Biotech, Inc. | -2.22 Million USD | -1634.243% |
| Eiger BioPharmaceuticals, Inc. | -71.78 Million USD | 46.129% |
| Nanobac Pharmaceuticals, Incorporated | 4.91 Million USD | 886.836% |
| GeneThera, Inc. | - USD | Infinity% |
| Emmaus Life Sciences, Inc. | 3.54 Million USD | 1192.416% |
| Adynxx, Inc. | - USD | Infinity% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -2417.596% |
| Marizyme, Inc. | -34.08 Million USD | -13.451% |
| Nymox Pharmaceutical Corporation | -8.35 Million USD | -363.132% |
| Alseres Pharmaceuticals, Inc. | -564.72 Thousand USD | -6747.873% |
| Zenith Capital Corp. | -8.94 Million USD | -332.422% |
| Intellipharmaceutics International Inc. | -2.85 Million USD | -1256.654% |
| Halberd Corporation | -75.05 Thousand USD | -51427.666% |
| Genus plc | 6.4 Million USD | 704.242% |
| Pharming Group N.V. | -4.87 Million USD | -692.523% |
| MetaStat, Inc. | - USD | Infinity% |
| Therapeutic Solutions International, Inc. | -1.98 Million USD | -1846.737% |
| Affymax, Inc. | -15.04 Million USD | -157.022% |
| SYBLEU INC | -149.18 Thousand USD | -25822.72% |
| Enzon Pharmaceuticals, Inc. | -1.04 Million USD | -3604.168% |
| Enzolytics Inc. | -2.14 Million USD | -1699.679% |
| argenx SE | -425.04 Million USD | 90.902% |
| AVAX Technologies, Inc. | 6.69 Million USD | 677.801% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -2658.328% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -2795.808% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Accustem Sciences Inc. | -3.74 Million USD | -932.226% |
| NDT Pharmaceuticals Inc. | -25.17 Thousand USD | -153541.291% |
| Cell Source, Inc. | -4.32 Million USD | -794.068% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -483.06 Thousand USD | -7905.497% |
| Q BioMed Inc. | -3.44 Million USD | -1022.34% |
| Rasna Therapeutics, Inc. | -4.23 Million USD | -812.405% |
| Capstone Therapeutics Corp. | -1.25 Million USD | -2978.942% |
| Mosaic ImmunoEngineering Inc. | -2.62 Million USD | -1371.786% |
| PsyBio Therapeutics Corp. | -4.55 Million USD | -749.041% |
| American Oriental Bioengineering, Inc. | -54.97 Million USD | 29.653% |
| Provectus Biopharmaceuticals, Inc. | -2.9 Million USD | -1232.926% |
| Rebus Holdings, Inc. | -664 Thousand USD | -5724.023% |
| Helix BioMedix, Inc. | -984.05 Thousand USD | -3829.82% |
| Skye Bioscience, Inc. | -13.67 Million USD | -182.856% |
| GlobeStar Therapeutics Corporation | -1.86 Million USD | -1974.24% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | -1828.988% |
| ONE Bio Corp. | 13.68 Million USD | 382.654% |
| Curative Biotechnology, Inc. | -1.93 Million USD | -1900.999% |
| Wesana Health Holdings Inc. | -1.12 Million USD | -3337.755% |
| Agentix Corp. | -1.37 Million USD | -2719.125% |
| Endonovo Therapeutics, Inc. | -2.91 Million USD | -1224.619% |
| RespireRx Pharmaceuticals Inc. | -1.57 Million USD | -2348.564% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -221882.165% |
| Kadimastem Ltd | -3.04 Million USD | -1171.985% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -261.72 Thousand USD | -14675.572% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -9207.694% |
| NovAccess Global Inc. | -2.46 Million USD | -1467.705% |
| Itoco Inc. | -919.14 Thousand USD | -4107.358% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NanoSphere Health Sciences Inc. | -220.07 Thousand USD | -17471.73% |
| Qrons Inc. | -643.67 Thousand USD | -5907.907% |
| Mobile Lads Corp. | -554.55 Thousand USD | -6873.494% |
| Genscript Biotech Corporation | -415.79 Million USD | 90.699% |
| International Stem Cell Corporation | -663 Thousand USD | -5732.807% |
| Bioxytran, Inc. | -3.82 Million USD | -912.304% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -73364.12% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -20.34 Thousand USD | -190025.433% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -36.26 Million USD | -6.633% |
| Adhera Therapeutics, Inc. | -1.61 Million USD | -2290.081% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -735.83 Thousand USD | -5155.46% |
| Innovation Pharmaceuticals Inc. | -3.11 Million USD | -1143.057% |
| Neutra Corp. | -229.48 Thousand USD | -16751.36% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -120.489% |
| PureTech Health plc | -146.19 Million USD | 73.549% |
| Coeptis Therapeutics, Inc. | -21.49 Million USD | -79.942% |
| IXICO plc | -1.43 Million USD | -2591.128% |
| IntelGenx Technologies Corp. | -9.49 Million USD | -307.455% |
| Gelesis Holdings, Inc. | -121.8 Million USD | 68.252% |
| CSL Limited | 3.81 Billion USD | 101.014% |
| Cellectis S.A. | -108.85 Million USD | 64.475% |